Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. RAXONE (idébénone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

RAXONE (idébénone)

Medicine - Posted on Mar 03 2022
Active substance (DCI)
  • idébénone
history (2)
  • 1/19/22

    RAXONE 150 mg (idébénone)

    Key points Favourable opinion for reimbursement in the treatment of visual impairment in adolescent and adult patients with ...
    CAV :
    54321
    icône flèche
  • 3/16/16

    RAXONE (idebenone), ophthalmic medicinal product

    Insufficient clinical benefit in Leber's hereditary optic neuropathy because of the lack of methodologically acceptable clin...
    icône flèche
Technical information
ATC code
  • N06BX13
Manufacturer
SANTHERA PHARMACEUTICALS GmbH
Presentation

RAXONE 150 mg, comprimés pelliculés
B/180 - (Code CIP : 34009 300 245 6 0)

All our publications
    Congenital, genetic and rare diseases Drug therapy Eye diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
pzNdUaq8ux561Zq8